Get started
Author

Antonia P. Gunesch

Observed names: Antonia Gunesch, Antonia-Patricia Gunesch, Gunesch, Antonia P.
ORCID: 0000-0003-2649-7556
Observed ORCID: 0000-0003-2649-7556
OpenAlex ID: A5080069578
Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
2021 · Melanie Ricke-Hoch, Elisabeth Stelling, et al. · PLoS ONE · 82
PDF
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
2024 · Svenja M. Sake, Xiaoyu Zhang, et al. · Nature Communications · 48
PDF
Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
2021 · Francisco J. Zapatero-Belinchón, Rebecca Moeller, et al. · iScience · 25
PDF
Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA‐Virus Inhibitors**
2022 · Patrick A. Haack, Kirsten Harmrolfs, et al. · Angewandte Chemie International Edition · 22
PDF
Discovery of the Pendulisporaceae: An extremotolerant myxobacterial family with distinct sporulation behavior and prolific specialized metabolism
2024 · Ronald Garcia, Alexander Popoff, et al. · Chem · 18
Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis
2020 · Antonia P. Gunesch, Francisco J. Zapatero-Belinchón, et al. · Antimicrobial Agents and Chemotherapy · 17
Persicamidines—Unprecedented Sesquarterpenoids with Potent Antiviral Bioactivity against Coronaviruses
2022 · Lena Keller, Emilia Oueis, et al. · Angewandte Chemie International Edition · 15
PDF
Effect of statins on SARS-CoV-2 infection
2020 · Rebecca Moeller, Francisco J. Zapatero-Belinchón, et al. · medRxiv · 12
PDF
Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets
2024 · Sibylle Haid, Alina Matthaei, et al. · Antimicrobial Agents and Chemotherapy · 10
Respiratory Syncytial Virus Two-Step Infection Screen Reveals Inhibitors of Early and Late Life Cycle Stages
2022 · Svenja M. Sake, Christina Kosch, et al. · Antimicrobial Agents and Chemotherapy · 7
Unlocking the antiviral arsenal: Structure-guided optimization of small-molecule inhibitors against RSV and hCoV-229E
2025 · Christina Karhan, Svenja M. Sake, et al. · European Journal of Medicinal Chemistry · 3
Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS‐CoV‐2
2024 · Ravindra P. Jumde, Gwenaëlle Jézéquel, et al. · Chemistry - A European Journal · 3
PDF
Validation of Small‐Molecule Entry Inhibitors Targeting the Respiratory Syncytial Virus
2026 · Christina Karhan, Svenja M. Sake, et al. · ChemMedChem
PDF
Fragment screenings afford inhibitors of SARS-CoV-2 non-structural protein 10
2026 · Anna Hirsch, Hugo Scherer, et al. · Research Square
PDF
Persicamidine – Außergewöhnliche Sesquarterpenoide mit potenter antiviraler Bioaktivität gegen Coronaviren
2022 · Lena Keller, Emilia Oueis, et al. · Angewandte Chemie
PDF
Thiamyxine: Struktur und Biosynthese myxobakterieller RNA‐Virus Inhibitoren**
2022 · Patrick A. Haack, Kirsten Harmrolfs, et al. · Angewandte Chemie
PDF
Works count: 17
Citation count: 262
H-index: 9
I10-index: 9
Year
Topic
Type